Does Sodium Chloride Sodium Lactate Potassium Chloride Calcium Ch Interact with Repository Corticotropin?
CDI records a major classification for Sodium Chloride Sodium Lactate Potassium Chloride Calcium Ch and Repository Corticotropin. The stored summary is: Avoid concomitant use due to increased risk of hypernatremia and volume overload. If unavoidable, closely monitor serum electrolytes and fluid balance. The mechanism involves drugs associated with sodium and fluid retention. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Repository Corticotropin Class
- Adrenocorticotropic Hormone
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Drugs associated with sodium and fluid retention
What To Tell Your Doctor or Pharmacist
If you are taking Sodium Chloride Sodium Lactate Potassium Chloride Calcium Ch and your doctor is considering prescribing Repository Corticotropin (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider